Clinical Trial Update: Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

This entry notes an extension of a Phase 3 trial comparing vildagliptin to rosiglitazone in drug-naive patients with Type 2 diabetes, focusing on efficacy and s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)
• Vildagliptin (vildagliptin)

Snippet

Sponsor: Novartis | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED